EGFR and lung carcinoma: Afatinib (Afb), a chemotherapeutic drug approved for the treatment of EGFR positive lung cancer, has been conjugated with AuNPs, to improving drug efficacy and biocompatibility, administered to in vitro lung cancer cells.